Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can Pfizer's Stock Keep Climbing?

TheMotleyFool

0 0

The big news regarding Pfizer (NYSE: PFE) these days centers on its search for a COVID-19 vaccine, but that just obscures more important news for investors. This solid, 171-year-old, diversified pharmaceutical company with more than 88,000 employees looks to have a nice surprise in store for investors this year -- and it's still priced reasonably.

It seems as if every pharmaceutical company is working on a COVID-19 vaccine these days, and that includes New York City-based Pfizer.

IMAGE SOURCE: GETTY IMAGES

Source Fool.com

Like: 0

PFE

Share